Use of methylene amide derivatives in cardiovascular disorders

Details for Australian Patent Application No. 2005216649 (hide)

Owner Merck Serono SA

Inventors Richard, Vincent; Hooft Van Huijsduijnen, Rob

Agent Griffith Hack

Pub. Number AU-B-2005216649

PCT Pub. Number WO2005/082347

Priority 04100778.2 27.02.04 EP

Filing date 25 February 2005

Wipo publication date 9 September 2005

Acceptance publication date 9 September 2010

International Classifications

A61K 31/197 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/082347 Priority application(s): WO2005/082347

9 November 2006 Change of Name(s) of Applicant(s), Section 104

  Apllied Research Systems ARS Holding N.V. The name of the applicant has been changed to Applied Research Systems ARS Holding N.V.

25 October 2007 Assignment before Grant

  Applied Research Systems ARS Holding N.V The application has been assigned to Laboratoires Serono SA

30 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA

9 September 2010 Application Accepted

  Published as AU-B-2005216649

13 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005216651-Treatment of interstitial cystitis with vitamin D compounds

2005216648-Hyaluronic acid derivative based threedimensional matrix